Agajanian Institute Of Oncology is categorized under Oncologists in Downey, CA and active since 2007.
Agajanian Institute Of Oncology was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Hilda Agajanian at the company’s single location by writing to 7735 Brookmill Road, Downey, California CA 90241 or by phoning (562) 869-1201. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Agajanian Institute Of Oncology |
Contact Person: | Hilda Agajanian |
Address: | 7735 Brookmill Road, Downey, California 90241 |
Phone Number: | (562) 869-1201 |
Website Address: | theoncologyinstitute.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Oncologists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Agajanian Institute Of Oncology was started in 2007 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Hilda Agajanian for inquiries that concern Agajanian Institute Of Oncology by calling the company number (562) 869-1201, as your correspondence is most welcome. Additionally, the physical location of the single location of Agajanian Institute Of Oncology can be found at the coordinates 33.940239,-118.145839 as well as the street address 7735 Brookmill Road in Downey, California 90241.
For its online presence, you may visit Agajanian Institute Of Oncology’s website at theoncologyinstitute.com and engage with its social media outlets through on Twitter and on Facebook.